358 related articles for article (PubMed ID: 29703689)
1. Comparing Accuracy of Mammography and Magnetic Resonance Imaging for Residual Calcified Lesions in Breast Cancer Patients Undergoing Neoadjuvant Systemic Therapy.
Um E; Kang JW; Lee S; Kim HJ; Yoon TI; Sohn G; Chung IY; Kim J; Lee JW; Son BH; Ahn SH; Ko BS
Clin Breast Cancer; 2018 Oct; 18(5):e1087-e1091. PubMed ID: 29703689
[TBL] [Abstract][Full Text] [Related]
2. Residual Mammographic Microcalcifications and Enhancing Lesions on MRI After Neoadjuvant Systemic Chemotherapy for Locally Advanced Breast Cancer: Correlation with Histopathologic Residual Tumor Size.
Kim YS; Chang JM; Moon HG; Lee J; Shin SU; Moon WK
Ann Surg Oncol; 2016 Apr; 23(4):1135-42. PubMed ID: 26628432
[TBL] [Abstract][Full Text] [Related]
3. Change in microcalcifications on mammography after neoadjuvant chemotherapy in breast cancer patients: correlation with tumor response grade and comparison with lesion extent.
Yim H; Ha T; Kang DK; Park SY; Jung Y; Kim TH
Acta Radiol; 2019 Feb; 60(2):131-139. PubMed ID: 29764199
[TBL] [Abstract][Full Text] [Related]
4. MRI prediction of neoadjuvant chemotherapy response is equivalent in patients with or without mammographic calcifications: a step towards adapting surgical approach?
Sella T; Simor B; Adler-Levy Y; Maly B; Kadouri L; Carmon E
Eur Radiol; 2023 Oct; 33(10):7168-7177. PubMed ID: 37086288
[TBL] [Abstract][Full Text] [Related]
5. Residual microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer: comparison of the accuracies of mammography and MRI in predicting pathological residual tumor.
An YY; Kim SH; Kang BJ
World J Surg Oncol; 2017 Nov; 15(1):198. PubMed ID: 29110671
[TBL] [Abstract][Full Text] [Related]
6. Calcifications on mammogram do not correlate with tumor size after neoadjuvant chemotherapy.
Weiss A; Lee KC; Romero Y; Ward E; Kim Y; Ojeda-Fournier H; Einck J; Blair SL
Ann Surg Oncol; 2014 Oct; 21(10):3310-6. PubMed ID: 25056851
[TBL] [Abstract][Full Text] [Related]
7. Prediction of Residual Malignancy After Excisional Biopsy for Breast Cancer With Suspicious Microcalcifications: Comparison of Mammography and Magnetic Resonance Imaging.
Park G; Bae K; Hwang IY; Kim JS; Kwon WJ; Bang M
Clin Breast Cancer; 2019 Dec; 19(6):e753-e758. PubMed ID: 31182403
[TBL] [Abstract][Full Text] [Related]
8. Contrast-Enhanced Spectral Mammography is Comparable to MRI in the Assessment of Residual Breast Cancer Following Neoadjuvant Systemic Therapy.
Patel BK; Hilal T; Covington M; Zhang N; Kosiorek HE; Lobbes M; Northfelt DW; Pockaj BA
Ann Surg Oncol; 2018 May; 25(5):1350-1356. PubMed ID: 29516362
[TBL] [Abstract][Full Text] [Related]
9. Preoperative evaluation of mammographic microcalcifications after neoadjuvant chemotherapy for breast cancer.
Kim EY; Do SI; Yun JS; Park YL; Park CH; Moon JH; Youn I; Choi YJ; Ham SY; Kook SH
Clin Radiol; 2020 Aug; 75(8):641.e19-641.e27. PubMed ID: 32291081
[TBL] [Abstract][Full Text] [Related]
10. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
Feliciano Y; Mamtani A; Morrow M; Stempel MM; Patil S; Jochelson MS
Ann Surg Oncol; 2017 Jun; 24(6):1492-1498. PubMed ID: 28058550
[TBL] [Abstract][Full Text] [Related]
11. MRI, Clinical Examination, and Mammography for Preoperative Assessment of Residual Disease and Pathologic Complete Response After Neoadjuvant Chemotherapy for Breast Cancer: ACRIN 6657 Trial.
Scheel JR; Kim E; Partridge SC; Lehman CD; Rosen MA; Bernreuter WK; Pisano ED; Marques HS; Morris EA; Weatherall PT; Polin SM; Newstead GM; Esserman LJ; Schnall MD; Hylton NM;
AJR Am J Roentgenol; 2018 Jun; 210(6):1376-1385. PubMed ID: 29708782
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic correlation of residual mammographic microcalcifications after neoadjuvant chemotherapy for locally advanced breast cancer.
Adrada BE; Huo L; Lane DL; Arribas EM; Resetkova E; Yang W
Ann Surg Oncol; 2015 Apr; 22(4):1111-7. PubMed ID: 25287438
[TBL] [Abstract][Full Text] [Related]
13. Comparison of mammography, digital breast tomosynthesis, automated breast ultrasound, magnetic resonance imaging in evaluation of residual tumor after neoadjuvant chemotherapy.
Park J; Chae EY; Cha JH; Shin HJ; Choi WJ; Choi YW; Kim HH
Eur J Radiol; 2018 Nov; 108():261-268. PubMed ID: 30396666
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Posttreatment Imaging for Evaluation of Residual in Breast Disease After Neoadjuvant Endocrine Therapy.
Zhang C; Kosiorek HE; Patel BK; Pockaj BA; Ahmad SB; Cronin PA
Ann Surg Oncol; 2022 Oct; 29(10):6207-6212. PubMed ID: 35831526
[TBL] [Abstract][Full Text] [Related]
15. Human Epidermal Growth Factor 2-positive Breast Cancer with Mammographic Microcalcification: Relationship to Pathologic Complete Response after Neoadjuvant Chemotherapy.
Mazari FAK; Sharma N; Dodwell D; Horgan K
Radiology; 2018 Aug; 288(2):366-374. PubMed ID: 29786482
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer molecular phenotype and the use of HER2-targeted agents influence the accuracy of breast MRI after neoadjuvant chemotherapy.
Moon HG; Han W; Ahn SK; Cho N; Moon WK; Im SA; Park IA; Noh DY
Ann Surg; 2013 Jan; 257(1):133-7. PubMed ID: 22968080
[TBL] [Abstract][Full Text] [Related]
17. Imaging findings for response evaluation of ductal carcinoma in situ in breast cancer patients treated with neoadjuvant systemic therapy: a systematic review and meta-analysis.
Ploumen RAW; de Mooij CM; Gommers S; Keymeulen KBMI; Smidt ML; van Nijnatten TJA
Eur Radiol; 2023 Aug; 33(8):5423-5435. PubMed ID: 37020070
[TBL] [Abstract][Full Text] [Related]
18. Multiparametric MR imaging to assess response following neoadjuvant systemic treatment in various breast cancer subtypes: Comparison between different definitions of pathologic complete response.
Santamaría G; Bargalló X; Ganau S; Alonso I; Muñoz M; Mollà M; Fernández PL; Prat A
Eur J Radiol; 2019 Aug; 117():132-139. PubMed ID: 31307638
[TBL] [Abstract][Full Text] [Related]
19. Dynamic Contrast-enhanced Breast MRI for Evaluating Residual Tumor Size after Neoadjuvant Chemotherapy.
Kim SY; Cho N; Park IA; Kwon BR; Shin SU; Kim SY; Lee SH; Chang JM; Moon WK
Radiology; 2018 Nov; 289(2):327-334. PubMed ID: 30152744
[TBL] [Abstract][Full Text] [Related]
20. Breast MRI for Evaluating Residual Tumor Size Following Neoadjuvant Chemotherapy: Clinicopathologic Factors and MRI Imaging Features Affecting its Accuracy.
Park JY; Kim YS; Lee SE
Curr Med Imaging; 2022; 18(8):876-882. PubMed ID: 34789137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
